Efficacy and safety of saxagliptin 5 mg once-daily therapy in elderly patients with type 2 diabetes mellitus

被引：0

作者：

Maheux, P. ^{[1
]}

Doucet, J. ^{[2
]}

Allen, E. ^{[3
]}

Ravichandran, S. ^{[3
]}

Harris, S.

Chen, R. ^{[3
]}

Brulle, C. ^{[4
]}

机构：

[1] AstraZeneca ISMO Europe, Brussels, Belgium

[2] CHU Rouen, Rouen, France

[3] Bristol Myers Squibb Co, Princeton, NJ USA

[4] Bristol Myers Squibb EMEA, Paris, France

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

766

引用

页码：S302 / S302

页数：1

共 50 条

[41] Efficacy and safety of lixisenatide once-daily versus exenatide twice-daily in patients with type 2 diabetes insufficiently controlled on metformin (GetGoal-X)
Rosenstock, J.
Raccah, D.
Koranyi, L.
Maffei, L.
Boka, G.
Miossec, P.
Gerich, J. E.
DIABETOLOGIA, 2011, 54 : S317 - S318
[42] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
Fukuda, Masahiro
Doi, Kunihiro
Sugawara, Masahiro
Mochizuki, Koichi
JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 383 - 391
[43] Efficacy and Safety of Once Daily Remogliflozin Etabonate for the Treatment of Type 2 Diabetes
Sykes, Andy
Wilkison, William O.
Kler, Lata
Kemp, Gail
Almond, Steve
Dobbins, Robert L.
O'Connor-Semmes, Robin
DIABETES, 2014, 63 : A287 - A287
[44] Efficacy and Safety of Saxagliptin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
Barrett, Yu Chen
Minervini, Gianmaria
Chen, Hungta
Ghannam, Ameen
DIABETES, 2015, 64 : A323 - A323
[45] EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD
Soule, Tedi
Caveney, Scott
Tombs, Lee
Naya, Ian
Boucot, Isabelle
CHEST, 2018, 154 (04) : 750A - 750A
[46] Efficacy and safety of once-daily amlodipine in patients with stable angina pectoris
Haringer, E
SauerbreyWullkopf, N
MEDIZINISCHE WELT, 1996, 47 (04): : 175 - 180
[47] Detemir as a once-daily basal insulin in type 2 diabetes
Nelson, Scott E.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
[48] A Pooled Analysis of the Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes
Hirshberg, Boaz
Bryzinski, Brian
Xu, John
Iqbal, Nayyar
JOURNAL OF DIABETES & METABOLISM, 2015, 6 (04)
[49] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
Vianna, Andre G. D.
Desouza, Cyrus
Laugesen, Christian
Marques, Mariana Fragao
Nielsen, Pernille Hojlund
Shaikh, Shehla S.
Lingvay, Ildiko
DIABETES, 2024, 73
[50] Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis
Hirshberg, Boaz
Bryzinski, Brian
Xu, John
Monyak, John
Iqbal, Nayyar
DIABETES, 2014, 63 : A610 - A610

← 1 2 3 4 5 →